Literature DB >> 9178918

Sleep apnea, norepinephrine-release rate, and daytime hypertension.

M G Ziegler1, R Nelesen, P Mills, S Ancoli-Israel, B Kennedy, J E Dimsdale.   

Abstract

Patients with obstructive sleep apnea (OSA) are often hypertensive, and both apneics and hypertensives are reported to have increased sympathetic nerve activity. We measured plasma norepinephrine (NE) levels, clearance, and release rate among 65 subjects who breathed room air, a hypoxic gas mixture, and the hypoxic mixture combined with intermittent breath holding. Apneics' plasma NE across all three breathing conditions was 307 pg/ml compared with the non-apneics' level of 248 pg/ml (p = 0.017). NE clearance increased from 3.2 l/minute to 3.9 l/minute when subjects breathed a hypoxic gas mixture (p < 0.001). NE clearance was similar among normal controls, apneics, and hypertensives. The rate at which NE was released from sympathetic nerves into the bloodstream was higher among hypertensives but not among apneics while subjects breathed room air. Hypoxia increased the NE-release rate from 892 ng/minute to 1,042 ng/minute (p < 0.001) and increased the NE-release rate more among apneics than non-apneics (p < 0.001). The NE-release rate response to hypoxia and breath holding differed between hypertensives and normotensives (p < 0.001) and between apneics and non-apneics (p < 0.001). Normotensive apneics had the largest increase in NE release during hypoxia. Like other investigators, we found that plasma NE levels were increased among apneics. Calculation of NE-release rate and correction for blood pressure status revealed a more complex situation. Apneics breathing room air had a normal NE-release rate; any increase in sympathetic neuronal NE release could be attributed to apneics who were also hypertensive. However, apneics had a greater NE response to hypoxia. These results suggest that apneics are susceptible to transient increases in sympathetic nervous activity and that hypertensive apneics maintain increased sympathetic nervous release of NE in the daytime.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178918     DOI: 10.1093/sleep/20.3.224

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  18 in total

Review 1.  The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea.

Authors:  Valeria Bisogni; Martino F Pengo; Giuseppe Maiolino; Gian Paolo Rossi
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

2.  Complete blood count alterations after six months of continuous positive airway pressure treatment in patients with severe obstructive sleep apnea.

Authors:  Sinem Nedime Sökücü; Cengiz Ozdemir; Levent Dalar; Levent Karasulu; Senay Aydın; Sedat Altın
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

3.  Obstructive sleep apnea and cardiovascular disease.

Authors:  David E Green; David A Schulman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-08

4.  Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats.

Authors:  John M Dopp; Nathan R Philippi; Noah J Marcus; E Burt Olson; Cynthia E Bird; John J M Moran; Scott W Mueller; Barbara J Morgan
Journal:  Respiration       Date:  2011-08-12       Impact factor: 3.580

5.  Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells.

Authors:  Guoxiang Yuan; Gautam Adhikary; Andrew A McCormick; John J Holcroft; Ganesh K Kumar; Nanduri R Prabhakar
Journal:  J Physiol       Date:  2004-04-23       Impact factor: 5.182

Review 6.  Transcriptional responses to intermittent hypoxia.

Authors:  Jayasri Nanduri; Guoxiang Yuan; Ganesh K Kumar; Gregg L Semenza; Nanduri R Prabhakar
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

Review 7.  Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor?

Authors:  Nikolaos Zias; Vishnu Bezwada; Sean Gilman; Alexandra Chroneou
Journal:  Sleep Breath       Date:  2008-09-03       Impact factor: 2.816

Review 8.  Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients.

Authors:  Robert P Blankfield
Journal:  Sleep Breath       Date:  2002-12       Impact factor: 2.816

9.  Hypertension and catecholamine levels in sleep apnoea.

Authors:  Vasu Vardhan; K Shanmuganandan
Journal:  Med J Armed Forces India       Date:  2012-01-18

Review 10.  Sleep apnea and hypertension.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.